Lifecore Biomedical, Inc. LFCR Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s investing cash flow?
- Lifecore Biomedical, Inc. (LFCR) reported investing cash flow of -$1.12M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s investing cash flow changed year-over-year?
- Lifecore Biomedical, Inc.'s investing cash flow increased by 46.7% year-over-year, from -$2.1M to -$1.12M.
- What is the long-term trend for Lifecore Biomedical, Inc.'s investing cash flow?
- Over 2 years (2023 to 2025), Lifecore Biomedical, Inc.'s investing cash flow has grown at a 15.5% compound annual growth rate (CAGR), from -$4.81M to -$6.42M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.